Clinical spectrum and outcomes of crescentic glomerulonephritis: A single center experience.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27512296)

Published in Indian J Nephrol on August 11, 2016

Authors

S K Rampelli1, N G Rajesh2, B H Srinivas2, K T Harichandra Kumar3, R P Swaminathan1, P S Priyamvada4

Author Affiliations

1: Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
2: Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
3: Department of Biometrics, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
4: Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Articles cited by this

Rapidly progressive crescentic glomerulonephritis. Kidney Int (2003) 2.17

Antineutrophil cytoplasmic autoantibody-negative Pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol (2007) 1.48

Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol (2008) 1.46

Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant (2000) 1.45

Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int (2009) 1.37

Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. J Am Soc Nephrol (2013) 1.20

Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India (2004) 1.14

Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. Clin Exp Rheumatol (1998) 1.03

Clinical spectrum and outcome of crescentic glomerulonephritis in children in developing countries. Pediatr Nephrol (2007) 1.00

Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis (1987) 0.97

Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc (2006) 0.95

Pattern of glomerular diseases among adults in Rajshahi, the Northern Region of Bangladesh. Saudi J Kidney Dis Transpl (2012) 0.89

Clinical and histological outcome predictors in renal limited pauci-immune crescentic glomerulonephritis: a single centre experience. Int J Immunopathol Pharmacol (2012) 0.87

Crescentic nephritis at Groote Schuur Hospital, South Africa--not a benign disease. Clin Nephrol (1994) 0.87

Etiology and outcome of crescentic glomerulonephritis. Indian Pediatr (2012) 0.86

The Pisa experience of renal biopsies, 1977-2005. J Nephrol (2007) 0.84

Crescentic glomerulonephritis: a clinical and histomorphological analysis of 46 cases. Indian J Pathol Microbiol (2011) 0.80

Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients. Chin Med J (Engl) (2003) 0.80

Clinicopathologic spectrum of crescentic glomerulonephritis: a hospital-based study. Saudi J Kidney Dis Transpl (2014) 0.80

Pathological spectrums and renal prognosis of severe lupus patients with rapidly progressive glomerulonephritis. Rheumatol Int (2014) 0.79

Glomerulonephritis with crescents among adult Saudi patients outcome and its predictors. Clin Exp Med (2011) 0.79

IgA nephropathy in a tertiary care center from south India. Indian J Nephrol (2011) 0.78

The immunopathological spectrum of crescentic glomerulonephritis: a survey of 106 patients in a single Chinese center. Nephron Clin Pract (2010) 0.77